This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (30) Citing Articles via Google Scholar Google Scholar Articles by Himmelseher, S. Articles by Durieux, M. E. Search for Related Content PubMed PubMed Citation Articles by Himmelseher, S. Articles by Durieux, M. E. Related Collections Trauma Neuroanesthesia Pharmacology

---

NEUROSURGICAL ANESTHESIA

Revising a Dogma: Ketamine for Patients with Neurological Injury?

Sabine Himmelseher, MD^*, and Marcel E. Durieux, MD, PhD

*Klinik fuer Anaesthesiologie, Klinikum rechts der Isar, Technische Universität, München, Germany; and Department of Anesthesiology, University of Virginia Health System, Charlottesville, Virginia

Address correspondence and reprint requests to Marcel E. Durieux, MD, PhD, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, VA 22908-0710. Address e-mail to durieux{at}virginia.edu.

We evaluated reports of randomized clinical trials in the perioperative and intensive care setting concerning ketamine’s effects on the brain in patients with, or at risk for, neurological injury. We also reviewed other studies in humans on the drug’s effects on the brain, and reports that examined ketamine in experimental brain injury. In the clinical setting, level II evidence indicates that ketamine does not increase intracranial pressure when used under conditions of controlled ventilation, coadministration of a -aminobutyric acid (GABA) receptor agonist, and without nitrous oxide. Ketamine may thus safely be used in neurologically impaired patients. Compared with other anesthetics or sedatives, level II and III evidence indicates that hemodynamic stimulation induced by ketamine may improve cerebral perfusion; this could make the drug a preferred choice in sedative regimes after brain injury. In the laboratory, ketamine has neuroprotective, and S(+)-ketamine additional neuroregenerative effects, even when administered after onset of a cerebral insult. However, improved outcomes were only reported in studies with brief recovery observation intervals. In developing animals, and in certain brain areas of adult rats without cerebral injury, neurotoxic effects were noted after large-dose ketamine. These were prevented by coadministration of GABA receptor agonists.

This article has been cited by other articles:

				O. W. Sakowitz, K. L. Kiening, K. L. Krajewski, A. S. Sarrafzadeh, M. Fabricius, A. J. Strong, A. W. Unterberg, and J. P. Dreier Preliminary Evidence That Ketamine Inhibits Spreading Depolarizations in Acute Human Brain Injury Stroke, August 1, 2009; 40(8): e519 - e522. [Abstract] [Full Text] [PDF]

				F. Aroni, N. Iacovidou, I. Dontas, C. Pourzitaki, and T. Xanthos Pharmacological Aspects and Potential New Clinical Applications of Ketamine: Reevaluation of an Old Drug J. Clin. Pharmacol., August 1, 2009; 49(8): 957 - 964. [Abstract] [Full Text] [PDF]

				C. L Hammell and J D Henning Prehospital management of severe traumatic brain injury BMJ, May 19, 2009; 338(may19_1): b1683 - b1683. [Full Text]

				M. Gunning, Z. Perkins, and T. Quinn Trench entrapment: is ketamine safe to use for sedation in head injury? Emerg. Med. J., November 1, 2007; 24(11): 794 - 795. [Full Text] [PDF]

				J. G. Bovill Anesthetic Pharmacology: Reflections of a Section Editor Anesth. Analg., November 1, 2007; 105(5): 1186 - 1190. [Full Text] [PDF]

				A. R. Absalom, M. Lee, D. K. Menon, S. R. Sharar, T. De Smet, J. Halliday, M. Ogden, P. Corlett, G. D. Honey, and P. C. Fletcher Predictive performance of the Domino, Hijazi, and Clements models during low-dose target-controlled ketamine infusions in healthy volunteers Br. J. Anaesth., May 1, 2007; 98(5): 615 - 623. [Abstract] [Full Text] [PDF]

				S. Shibuta, S. Varathan, and T. Mashimo Ketamine and thiopental sodium: individual and combined neuroprotective effects on cortical cultures exposed to NMDA or nitric oxide Br. J. Anaesth., October 1, 2006; 97(4): 517 - 524. [Abstract] [Full Text] [PDF]